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We report here a proof-of-concept design of a multidomain cell-
penetrating peptide amphiphile (CPPA) which can self-assemble 
into fibrous nanostructures and swtich to spherical micelles upon 
enzymatic degradation by the matrix metalloproteinase-2 (MMP-
2) up-regulated in the tumour environment. Concomitant with this 
morphological transition, the cell-penetrating peptide (CPP), 
which was previously buried inside the CPPA fibers, could be 
presented on the surface of the CPPA micelles, enhancing their 
cell-penetrating ability. These multifunctional and enzyme-
responsive CPP nanostructures hold potential as nanocarriers for 
tumour-targeted intracelllular delivery of therapeutic and 
diagnostic agents. 
Cell-penetrating peptides (CPPs) are a family of short peptides 
that are capable of translocating across cell membranes 
effectively
1
. Since the discovery of the first CPP, more than two 
decades ago
2
, CPPs have been widely used to enhance the 
intracellular delivery of diverse molecules and particles
3, 4
, 
including chemotherapeutic drugs, peptides and proteins, 
nucleic acids, imaging agents, quantum dots and liposomes. 
Although the cellular uptake mechanism of CPPs is not fully 
understood, experimental evidences have shown that 
electrostatic interactions between the positively charged 
amino acid residues of CPPs and the negatively charged 
proteoglycans or glycosaminoglycans on the cell surface play 
an important role in the membrane translocation of CPPs, 
regardless of other possible mechanisms (endocytosis and 
macropinocytosis) involved
5
. However, the cationic property of 
CPPs also causes their non-selective electrostatic interactions 
with anionic biological molecules or membranes, leading to 
their poor tumour targeting ability
6
. To harness the power of 
CPPs for tumour-targeted delivery, a number of strategies 
have been developed to allow the in situ presentation of CPPs 
in response to endogenous disease conditions (pH, enzyme 
activities, redox potential) or locally applied exogenous stimuli 
(temperature, ultrasound, magnetic or electrical fields, light) 
only at the tumour site
7, 8
. However, the multiple 
functionalization steps involved in these strategies make both 
the preparation process and the final architectures complex. 
The design of multifunctional and stimuli-sensitive CPP 
nanostructures that could be formed in a single step would be 




     To deal with the aforementioned challenges, we designed a 
self-assembling cell-penetrating peptide amphiphile (CPPA) 
with multiple functional domains (Fig. S1): (i) a hydrophobic 
palmitic acid tail C16, which could act as the hydrophobic 
driving force for self-assembly
10
 and also provide the 
hydrophobic region for the entrapment of chemotherapeutic 
drugs
11, 12
; (ii) a CPP sequence YTA4 (IAWVKAFIRKLRKGPLG), 
which contains parts of the MMP-2 sensitive peptide sequence 
(GPLG)
13
. The cationic property of this CPP sequence adds 
amphiphilicity to the designed CPPA to favour its self-assembly 
and also enables the cell-penetrating ability of the assemblies; 
(iii) a MMP-2 sensitive octapeptide linker (GPLGIAGQ), which 
has been reported to be cleaved at the site between glycine 
(G) and isoleucine (I)
14
 by MMP-2 that is overexpressed and 
activated in the tumour environment
15, 16
, thus enabling the 
controlled presentation of CPP; and (iv) a targeting peptide 
moiety (RGDS), which could be specifically recognized by ανβ3 
and ανβ5 integrins overexpressed on the surface of tumour 
cells
17
. It could act as a shelter for the off-targeted CPP 
sequence upon self-assembly and enable the specific tumour 
accumulation of the assemblies. We hypothesized that the 
rationally designed CPPA could self-assemble into defined 
nanostructures in aqueous environment, with the targeting 
moiety being presented on the surface and the CPP sequence 
being buried inside of the assemblies. The targeting moiety on 
the surface of the assemblies could protect the off-targeted 
CPP, while allowing the specific accumulation of the 
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assemblies at the tumour site. The overexpression and 
activation of MMP-2 in the tumour environment could then 
initiate the cleavage of the MMP-2 sensitive linker and trigger 
the presentation of the CPP sequence to facilitate the 
penetration of the CPPA assemblies across the cell 
membranes. 
     Herein, the multi-domain self-assembling CPPA and its 
expected product from the MMP-2 enzymatic degradation 
(CPPAMMP) were firstly synthesized and purified (Fig. S2 and S3, 
ESI†). Their self-assembly behaviour and structural properties 
were then investigated by circular dichroism (CD) and 
fluorescence spectroscopy, transmission electron microscopy 
(TEM) and small angle X-ray scattering (SAXS). 
     The amphiphilicity of CPPA offers an opportunity to drive its 
self-assembly process. Using a sovatochromic fluorescence 
dye, Nile Red, which exhibits an increased fluorescence 
intensity and pronounced blue shift when encapsulated into 
the hydrophobic region of self-assembled nanostructures
18
, 
the critical aggregation concentration (CAC) of CPPA was 
determined at 0.02 mM (Fig. 1A). 
     To further characterize the structural properties of the 
CPPA assemblies, TEM together with SAXS were used to 
analyse their shape and size. As displayed in Fig. 1B, TEM 
observation revealed the formation of fibrous structures with 
a micron scale length and a roughly 18 nm diameter. This 
observation was confirmed by SAXS (Fig. 1C), which yielded a 
slope of -1, indicating the formation of cylindrical 
nanostructures. A polydisperse core-shell cylinder fit was 
applied to these cylindrical nanostructures and a diameter of 
2.3 ± 0.2 nm was calculated. The hydrodynamic diameter 
calculated from SAXS is mainly for the hydrophobic core of the 
CPPA fibres and therefore a smaller value was obtained 
compared to the mean diameter measured by TEM. 
     To investigate the enzyme responsiveness of the CPPA 
assemblies, CPPA fibres were incubated with active MMP-2 at 
37 
o
C and their cleavability was monitored over time by 
analytical RP-HPLC. As demonstrated in Fig. 2, at the starting 
point of incubation, only one peak was shown in the HPLC 
chromatogram, corresponding to the uncleaved CPPA. With 
increasing incubation time, the CPPA peak decreased, while an 
increasing new peak with longer retention time was observed. 
The extended retention time indicates the presence of a less 
polar product. ESI-MS analysis of the fraction collected from 
the increasing new peak showed a mass that corresponds to 
the expected peptide fragment after the MMP-2 degradation 
(Fig. S4, ESI†). In contrast, when CPPA fibres were incubated 
alone, without the active MMP-2 enzyme, no change was 
detected over time. These results suggested that the CPPA 
fibres can be fully cleaved by MMP-2, even though the MMP-2 
sensitive peptide sequence was conjugated with both CPP and 
targeting sequences at its two ends and buried inside the CPPA 
fibres. Our design on the controlled presentation of CPP upon 
degradation by MMP-2 was proved to be practical. 
     Upon enzymatic degradation, the shorter cleaved segment 
is released from the assemblies and the fine balance among 
the multiple intermolecular forces that hold the assemblies 
might be disturbed. As a consequence, a change in the self-
assembly behaviour could be triggered. Previous studies have 
reported the dissociation of self-assembled structures upon 
MMP degradation. For example, Hartgerink and co-workers 
have designed self-assembling multi-domain peptide based 
hydrogels that contained an MMP-2-specific cleavable domain. 
Enzyme-mediated digestion and collapse of the hydrogel was 
observed due to the disruption of the nanofibrous network
19
. 
Chau et al. have incorporated the MMP-2 sensitive sequence 
into self-assembling
20
 peptides for generating enzyme 
degradable nanofibrous scaffold hydrogels that could mimic 
the remodelling of natural extracellular matrix during tissue 
regeneration
21
. Cui’s lab has also used the MMP-2 peptide 
substrate for designing degradable peptide-based 
supramolecular filaments
22
. On the other hand, Xu’s group has 
provided compelling evidence that the MMP-9 enzyme could 
 
Fig. 1 Self-assembly behaviour of CPPA in Milli-Q water, pH 7.4: (A) maximum 
fluorescence emission wavelength and intensity of Nile Red as a function of CPPA 
concentration to determine the CAC of CPPA; (B) representative TEM image of 
CPPA (200 µM) showing fibrous nanostructures; (C) SAXS profile fitted with a core-
shell cylinder model for CPPA (2 mM); (D) CD spectrum of CPPA (50 µM) indicating 
α-helix secondary structure. 
 
Fig. 2 MMP-2 responsiveness of CPPA fibers: analytical RP-HPLC traces of 200 µM 
CPPA incubated with 20 nM active MMP-2 in TCNB buffer at 37 
o
C for different 
time intervals. 
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trigger the formation, instead of dissociation, of a short 
peptide based supramolecular hydrogel
23
. A micelle-to-fibre 
morphological transition of palmitylated PAs, induced by 
MMP-7, has been previously reported by Koda et al
24
 and the 
same morphological transition was accomplished via MMP-9 
cleavage of the phenylacetyl PAs designed by Ulijn’s group
25
. 
     Therefore, we further investigated whether the fibrous 
structure of the CPPA assemblies could be maintained after 
the enzymatic degradation by MMP-2. For this purpose, the 
self-assembly behaviour and structural properties of CPPAMMP 
were characterized. As shown in Fig. 3, CPPAMMP still hold the 
self-assembly ability, but a higher CAC of 0.08 mM is required 
to drive the self-assembly process. TEM imaging of CPPAMMP 
showed the formation of spherical micelles with a 20 nm 
diameter. The spherical morphology was further confirmed by 
SAXS, which yielded a slope of 0, indicating the presence of 
spherical micelles. A polydisperse core-shell sphere fit was 
applied to these spherical nanostructures and a diameter of 
2.9 ± 0.3 nm was calculated. These observations suggest that 
the designed CPPA can self-assemble into fibres in aqueous 
solution and reconfigure to spherical micelles upon MMP-2 
degradation. This fibre-to-micelle morphological transition 
offers an attractive method for the systemic delivery of 
therapeutic and diagnostic agents intracellularly. Following 
systemic delivery, fibrous structures are preferred over 
spherical counterparts as filamentous structures have been 
previously reported to remain in circulation 10 times longer 
than spherical particles
26
. A recent work developed at the 
Stupp’s lab also demonstrated that cylindrical nanostructures 
have the capacity of targeting injured blood vessels following 
systemic delivery, while spherical micelles with comparable 
diameter failed to bind
27
. However, spherical structures with 
relatively smaller and uniform size are more appealing over 




     To better understand the fibre-to-micelle morphological 
transition, secondary structure of CPPA and CPPAMMP was 
studied as it plays a significant role in the self-assembly of 
PAs
29, 30
. PAs with a β-sheet secondary structure typically yield 
elongated micelles due to the strong hydrogen bonding among 
the peptides that bring them close together, minimizing the 
curvature of the micelles
10
. On the other hand, PAs with a α-
helix secondary structure usually form spherical micelles
29, 31
, 
even though elongated micelles have also been observed
32, 33
. 
In particular, previous work by Tirrell’s group has 
demonstrated that assembled PA micelles undergo a spherical 
to cylindrical morphology transition over time with a switch in 
the secondary structure from α-helix to β-sheet
34
. However, 
CD spectra shown in Fig 1D and 3D revealed that both CPPA 
and CPPAMMP have an α-helix secondary structure at 
physiological pH. It is likely that, in addition to the hydrogen 
bonding, the electrostatic and steric forces could also affect 
the inter-peptide interactions and folding, contributing to the 
final morphology of the assemblies
27, 35, 36
. In the CPPA, the 
peptide interactions of the α-helix conformation are strong 
enough to hold them together tightly, resulting in fibrous 
nanostructures. However, the presence of charged side groups 
from lysine and arginine, at one end of the CPPAMMP sequence 
generate electrostatic repulsion forces, instead of cohesive 
forces, contributing to the formation of looser core-shell 
spherical micelles.  
     In order to verify our hypothesis, that the CPP sequence 
could be shielded inside the assemblies by the MMP-2 
sensitive and targeting sequences upon self-assembly, zeta-
potential measurements were performed. As expected, a 
lower zeta-potential for CPPA fibres (62.8±0.3 mV) was 
obtained compared to that of CPPAMMP spherical micelles 
(81.8±1.4 mV) at physiological pH in Milli-Q water, confirming 
that upon self-assembly, CPP sequence can be buried inside 
the assemblies and its positive charges can be partly shielded 
by the MMP-2 sensitive and targeting sequences.  
     In summary, we report here a proof-of-concept design of a 
multi-domain CPPA that can self-assemble into fibres in 
aqueous environment. The fibrous structure of the CPPA 
assemblies has a potential to prolong their circulation time in 
the blood stream. At the same time, active tumour 
accumulation could be achieved by the targeting moiety, 
which can also steric shield the CPP sequence and prevent the 
non-specific intracellular uptake of the CPPA fibres. Upon 
accumulation in the tumour environment, the overexpressed 
MMP-2 can cleave its sensitive linker, resulting in the 
detachment of the protective targeting moiety and exposing 
the previously hidden CPP sequence on the surface of the 
CPPA assemblies to facilitate the cell-penetrating process. 
Compared with conventional designs, the proposed 
multifunctional and enzyme-sensitive CPP nanostructures can 
be easily synthesized and fabricated via self-assembly. Their 
unique fibre-to-micelle morphological transition and 
controlled CPP presentation properties offer a greater 
possibility to achieve enhanced tumour cell targeting and 
 
Fig. 3 Self-assembly behaviour of CPPAMMP in Milli-Q water, pH 7.4: (A) maximum 
fluorescence emission wavelength and intensity of Nile Red as a function of 
CPPAMMP concentration to determine the CAC of CPPAMMP; (B) representative TEM 
image of CPPAMMP (200 µM) showing spherical micelle nanostructures; (C) SAXS 
profile fitted with a core-shell micelle model for CPPAMMP (2 mM); (D) CD spectrum 
of CPPAMMP (50 µM) indicating α-helix secondary structure. 
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penetrating. However, we are conscious that there are still 
several challenges ahead to optimize these CPP nanostructures 
for in vivo applications. First and foremost, the CAC value of 
the CPP nanostructures must be reduced to the nanomolar 
range to keep stable nanostructures during circulation
37
. 
Second, longer targeting peptide sequences or polymers may 
be needed to completely block the function of the CPP 
sequence. In our current design, although the CPP sequence 
could be shielded by the targeting moiety, as demonstrated by 
the decreased zeta-potential value, the positive charge of the 
CPPA fibres is still too high. Nonetheless, we demonstrated a 
valuable design for developing multifunctional and enzyme-
responsive CPP nanostructures with a greater possibility to 
achieve enhanced tumour accumulation and intracellular 
delivery of therapeutic and diagnostic. Further optimization of 
this CPPA design and in vitro evaluation of the CPP 
nanostructures are on-going in our lab. 
 
Acknowledgements 
Y. Shi thanks the China Scholarship Council for providing her a 
PhD Scholarship (No.201307060020) and the Postgraduate 
Research Fund from Queen Mary, University of London for 
supporting her short-term visit to Johns Hopkins University. 
 
Notes and references 
1. F. Milletti, Drug discovery today, 2012, 17, 850-860. 
2. A. D. Frankel and C. O. Pabo, Cell, 1988, 55, 1189-1193. 
3. E. Koren and V. P. Torchilin, Trends in molecular medicine, 
2012, 18, 385-393. 
4. F. Wang, Y. Wang, X. Zhang, W. Zhang, S. Guo and F. Jin, 
Journal of controlled release, 2014, 174, 126-136. 
5. D. M. Copolovici, K. Langel, E. Eriste and U. Langel, ACS 
nano, 2014, 8, 1972-1994. 
6. N. Q. Shi, X. R. Qi, B. Xiang and Y. Zhang, Journal of 
controlled release, 2014, 194, 53-70. 
7. Y. Huang, Y. Jiang, H. Wang, J. Wang, M. C. Shin, Y. Byun, 
H. He, Y. Liang and V. C. Yang, Advanced drug delivery 
reviews, 2013, 65, 1299-1315. 
8. S. R. MacEwan and A. Chilkoti, Wiley interdisciplinary 
reviews. Nanomedicine and nanobiotechnology, 2013, 5, 
31-48. 
9. M. S. Ekiz, G. Cinar, M. A. Khalily and M. O. Guler, 
Nanotechnology, 2016, 27, 402002. 
10. H. Cui, M. J. Webber and S. I. Stupp, Biopolymers, 2010, 
94, 1-18. 
11. M. O. Guler, R. C. Claussen and S. I. Stupp, J Mater Chem, 
2005, 15, 4507-4512. 
12. P. Zhang, A. G. Cheetham, Y. A. Lin and H. Cui, ACS nano, 
2013, 7, 5965-5977. 
13. M. Lindgren, K. Rosenthal-Aizman, K. Saar, E. Eiriksdottir, 
Y. Jiang, M. Sassian, P. Ostlund, M. Hallbrink and U. 
Langel, Biochem Pharmacol, 2006, 71, 416-425. 
14. H. Nagase and G. B. Fields, Peptide Science, 1996, 40, 399-
416. 
15. C. M. Overall and O. Kleifeld, Nature reviews. Cancer, 
2006, 6, 227-239. 
16. B. Schmalfeldt, D. Prechtel, K. Harting, K. Spathe, S. Rutke, 
E. Konik, R. Fridman, U. Berger, M. Schmitt, W. Kuhn and 
E. Lengyel, Clinical cancer research, 2001, 7, 2396-2404. 
17. E. Ruoslahti, Annual review of cell and developmental 
biology, 1996, 12, 697-715. 
18. M. C. A. Stuart, J. C. van de Pas and J. B. F. N. Engberts, J 
Phys Org Chem, 2005, 18, 929-934. 
19. K. M. Galler, L. Aulisa, K. R. Regan, R. N. D'Souza and J. D. 
Hartgerink, Journal of the American Chemical Society, 
2010, 132, 3217-3223. 
20. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. 
Murakami, M. Kimura, Y. Terada, M. R. Kano, K. 
Miyazono, M. Uesaka, N. Nishiyama and K. Kataoka, 
Nature nanotechnology, 2011, 6, 815-823. 
21. M. C. Giano, D. J. Pochan and J. P. Schneider, 
Biomaterials, 2011, 32, 6471-6477. 
22. Y. A. Lin, Y. C. Ou, A. G. Cheetham and H. Cui, 
Biomacromolecules, 2014, 15, 1419-1427. 
23. Z. Yang, M. Ma and B. Xu, Soft Matter, 2009, 5, 2546-
2548. 
24. D. Koda, T. Maruyama, N. Minakuchi, K. Nakashima and 
M. Goto, Chemical communications, 2010, 46, 979-981. 
25. D. Kalafatovic, M. Nobis, N. Javid, P. W. Frederix, K. I. 
Anderson, B. R. Saunders and R. V. Ulijn, Biomaterials 
science, 2015, 3, 246-249. 
26. Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, T. Minko 
and D. E. Discher, Nature nanotechnology, 2007, 2, 249-
255. 
27. T. J. Moyer, H. A. Kassam, E. S. Bahnson, C. E. Morgan, F. 
Tantakitti, T. L. Chew, M. R. Kibbe and S. I. Stupp, Small, 
2015, 11, 2750-2755. 
28. K. Huang, H. Ma, J. Liu, S. Huo, A. Kumar, T. Wei, X. Zhang, 
S. Jin, Y. Gan, P. C. Wang, S. He, X. Zhang and X. J. Liang, 
ACS nano, 2012, 6, 4483-4493. 
29. A. Trent, R. Marullo, B. Lin, M. Black and M. Tirrell, Soft 
Matter, 2011, 7, 9572-9582. 
30. S. R. Bull, M. O. Guler, R. E. Bras, T. J. Meade and S. I. 
Stupp, Nano letters, 2005, 5, 1-4. 
31. F. Boato, R. M. Thomas, A. Ghasparian, A. Freund‐
Renard, K. Moehle and J. A. Robinson, Angewandte 
Chemie International Edition, 2007, 46, 9015-9018. 
32. S. M. Standley, D. J. Toft, H. Cheng, S. Soukasene, J. Chen, 
S. M. Raja, V. Band, H. Band, V. L. Cryns and S. I. Stupp, 
Cancer research, 2010, 70, 3020-3026. 
33. D. Missirlis, M. Farine, M. Kastantin, B. 
Ananthanarayanan, T. Neumann and M. Tirrell, 
Bioconjugate chemistry, 2010, 21, 465-475. 
34. T. Shimada, S. Lee, F. S. Bates, A. Hotta and M. Tirrell, The 
journal of physical chemistry. B, 2009, 113, 13711-13714. 
35. A. Ghosh, E. T. Dobson, C. J. Buettner, M. J. Nicholl and J. 
E. Goldberger, Langmuir, 2014, 30, 15383-15387. 
36. T. J. Moyer, J. A. Finbloom, F. Chen, D. J. Toft, V. L. Cryns 
and S. I. Stupp, Journal of the American Chemical Society, 
2014, 136, 14746-14752. 
37. L. L. Lock, A. G. Cheetham, P. Zhang and H. Cui, ACS nano, 
2013, 7, 4924-4932. 
 
Page 4 of 4ChemComm
C
he
m
C
om
m
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
is
he
d 
on
 0
7 
Ju
ne
 2
01
7.
 D
ow
nl
oa
de
d 
by
 Q
ue
en
 M
ar
y,
 U
ni
ve
rs
ity
 o
f 
L
on
do
n 
on
 0
7/
06
/2
01
7 
15
:5
2:
51
. 
View Article Online
DOI: 10.1039/C7CC03512H
